Small Airway Mucous Metaplasia and Inflammation in Chronic Obstructive Pulmonary Disease

Mucous metaplasia is an important determinant of small airway obstruction in COPD. Its relationship to small airway inflammation is poorly defined. We analyzed 4 to 6 small airways in 19 COPD patients, GOLD stages 0–4, from lobectomy or lung volume reduction surgery tissue samples. To identify intracellular mucin, periodic acid fluorescent Schiff's (PAFS) stained slides were imaged by fluorescence microscopy. PAFS+ staining area, basement membrane length (LBM), epithelial height and area were measured. Mucin was expressed as a percentage of epithelial area. Mucin volume density (MVD) was calculated as PAFS+ area divided by the product of LBM and 4/π. Airways were Giemsa stained for eosinophils and immunostained with antibodies against CD3, CD4, CD8, CD68, and neutrophil elastase (NE), and the number of positively stained cells/mm2 was quantified in the airway wall. Mucin percent correlated with CD3+ cell density (r = 0.553, P < 0.0001), and MVD correlated with CD3+ (r = 0.570, P < 0.0001) and CD8+ cell density (r = 0.279, P = 0.016). There were weak negative correlations between mucin percent as well as MVD and CD68+ cell density (r = −0.270, P = 0.02 and r = −0.245, P = 0.036). There was no relationship between epithelial mucin content and CD4+, NE+, or eosinophil cell density. CD3+ and CD8+ lymphocytic inflammation is related to small airway mucous metaplasia in COPD and may play a causative role in its development.

[1]  David J Erle,et al.  IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production. , 2007, American journal of respiratory cell and molecular biology.

[2]  A. Agustí,et al.  Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease , 2006, Clinical and experimental immunology.

[3]  B. Make,et al.  Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.

[4]  I. Adcock,et al.  Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.

[5]  R. Djukanović,et al.  Inflammatory cells in the airways in COPD , 2006, Thorax.

[6]  Amir Sharafkhaneh,et al.  Airway mucus: From production to secretion. , 2006, American journal of respiratory cell and molecular biology.

[7]  H. Deshmukh,et al.  Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. , 2005, American journal of respiratory and critical care medicine.

[8]  B. Stripp,et al.  Mucin is produced by clara cells in the proximal airways of antigen-challenged mice. , 2004, American journal of respiratory cell and molecular biology.

[9]  D. Corry,et al.  An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema , 2004, PLoS medicine.

[10]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[11]  L. Fabbri,et al.  Interleukin‐13 and ‐4 expression in the central airways of smokers with chronic bronchitis , 2003, European Respiratory Journal.

[12]  M. Cosio,et al.  Pathophysiology of the small airways. , 2003, Seminars in respiratory and critical care medicine.

[13]  D. Corry,et al.  A Protease-Activated Pathway Underlying Th Cell Type 2 Activation and Allergic Lung Disease1 , 2002, The Journal of Immunology.

[14]  B. Beghé,et al.  Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. , 2002, American journal of respiratory and critical care medicine.

[15]  P. Paré,et al.  Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.

[16]  M. Saetta,et al.  Pathogenesis and Pathology of COPD , 2001, Respiration.

[17]  M. Miravitlles,et al.  Factors Associated with Increased Risk of Exacerbation and Hospital Admission in a Cohort of Ambulatory COPD Patients: A Multiple Logistic Regression Analysis , 2000, Respiration.

[18]  L. Fabbri,et al.  Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. , 2000, American journal of respiratory and critical care medicine.

[19]  M. Corradi,et al.  Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. , 1999, The Journal of allergy and clinical immunology.

[20]  L. Fabbri,et al.  Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.

[21]  L. Fabbri,et al.  Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. , 1997, American journal of respiratory and critical care medicine.

[22]  M. Stacey,et al.  The role of CD8+ Th2 lymphocytes in the development of smoking-related lung damage. , 1997, Biochemical and biophysical research communications.

[23]  J. Vestbo,et al.  Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.

[24]  W. MacNee,et al.  Factors affecting neutrophil transit during acute pulmonary inflammation: minireview. , 1993, Experimental lung research.

[25]  P. Schnohr,et al.  Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. , 1990, Thorax.

[26]  H. Yaegashi,et al.  Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[27]  D. Hyde,et al.  Regional differences in quantities of histochemically detectable mucosubstances in nasal, paranasal, and nasopharyngeal epithelium of the bonnet monkey. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  V. Kim,et al.  Small airway morphometry and improvement in pulmonary function after lung volume reduction surgery. , 2005, American journal of respiratory and critical care medicine.

[29]  J. Tyner,et al.  Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.